Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2
about
Research Advances in Tissue Engineering Materials for Sustained Release of Growth FactorsInjectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis.A review on carrier systems for bone morphogenetic protein-2Evaluation of a Novel HA/ZrO2-Based Porous Bioceramic Artificial Vertebral Body Combined with a rhBMP-2/Chitosan Slow-Release HydrogelFormulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration.Gelatin microspheres crosslinked with genipin for local delivery of growth factors.Intra-articular microparticles for drug delivery to the TMJDual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect modelTrehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivoDelivery of plasmid DNA encoding bone morphogenetic protein-2 with a biodegradable branched polycationic polymer in a critical-size rat cranial defect model.Evaluation of physical and mechanical properties of porous poly (ethylene glycol)-co-(L-lactic acid) hydrogels during degradation.Gelatin methacrylate microspheres for controlled growth factor releaseSustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats.Founder's award to Antonios G. Mikos, Ph.D., 2011 Society for Biomaterials annual meeting and exposition, Orlando, Florida, April 13-16, 2011: Bones to biomaterials and back again--20 years of taking cues from nature to engineer synthetic polymer sc3D Printing with Nucleic Acid Adhesives.Protein and mineral composition of osteogenic extracellular matrix constructs generated with a flow perfusion bioreactor.Controlled-release and preserved bioactivity of proteins from (self-assembled) core-shell double-walled microspheres.Strategies for controlled delivery of growth factors and cells for bone regenerationIGF-loaded silicon and zinc doped brushite cement: physico-mechanical characterization and in vivo osteogenesis evaluationGelatin-methacrylamide gel loaded with microspheres to deliver GDNF in bilayer collagen conduit promoting sciatic nerve growth.Osteochondral tissue regeneration using a bilayered composite hydrogel with modulating dual growth factor release kinetics in a rabbit model.2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering.Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nanoparticles.Mesenchymal stem cell and gelatin microparticle encapsulation in thermally and chemically gelling injectable hydrogels for tissue engineering.Polymer-based microparticles in tissue engineering and regenerative medicine.The use of micro- and nanospheres as functional components for bone tissue regeneration.Growth factor delivery: how surface interactions modulate release in vitro and in vivo.Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.IL-1Ra and its delivery strategies: inserting the association in perspective.Sustained delivery of biomolecules from gelatin carriers for applications in bone regeneration.Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects.Drug delivery from gelatin-based systems.The application of nanomaterials in controlled drug delivery for bone regeneration.Nanotechnology for protein delivery: Overview and perspectives.Hydrolysis and Sulfation Pattern Effects on Release of Bioactive Bone Morphogenetic Protein-2 from Heparin-Based Microparticles.Incorporation of growth factor loaded microspheres into polymeric electrospun nanofibers for tissue engineering applications.Characterization of recombinant human bone morphogenetic protein-2 delivery from injectable hyaluronan-based hydrogels by means of 125I-radiolabelling.Preparation and functional evaluation of cell aggregates incorporating gelatin microspheres with different degradabilities.Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation.Starch-poly-epsilon-caprolactone microparticles reduce the needed amount of BMP-2
P2860
Q26782690-EED813AA-05CE-4658-A732-4762720F9197Q27334661-D6648D71-E7D4-464A-A133-5957039F4B0CQ28271739-83339DF0-0B10-41DC-93BF-40A71DBD300EQ28552563-FC3DA03B-44EB-43F6-B7D0-648C1F47ACD0Q33639409-C5324EBB-659E-4639-8397-331DBF2F438FQ34282125-88307A2E-A890-4DA4-BF80-97FC1F061593Q34457610-098AE233-6EDC-4695-A132-371E98D7BE21Q34457622-EA7F1094-EB6D-4B3A-8A92-C16246D8AB63Q34566292-999B044F-BED5-4247-9370-30A1AC0F0DA9Q34600483-A135F63E-2178-41C4-8BEA-A3BE3E07EADDQ34673971-E279C9B1-6E61-4384-A067-B81F8FC95D00Q34944475-09C36FED-D6CF-472B-9A47-3BCEB905027BQ34973974-A744A607-EE5F-4E54-8292-93461178803EQ35168811-B697873B-90E0-40AA-8556-711E52E12957Q35589918-482DAF14-3582-4DA7-91DC-BF9CF993C9E0Q35616430-C483926C-D2AA-41FE-BAA3-C8A28CFA1E82Q35694277-CE8C76F3-A8F7-4E47-93A9-D2B93A0507FEQ35981629-2BE47F39-76A7-4C2E-BA41-0C9292ECD3C1Q36539382-49233527-75F5-4A1B-81DE-A205B0B90D0EQ36776620-72DAE82E-90AA-4BC2-9264-676668762640Q36867889-1584335A-514F-4B73-832E-1EA897598DA9Q37345739-9BF103E8-FA89-4C19-BC57-4091DE9CB467Q37439946-0DBB6B76-485B-4B65-8931-1414F8F5DAC2Q37666179-80D710FC-81C3-4588-B391-67E97DF03E29Q37876388-DAB19832-6DD1-40ED-8CE6-052525D30133Q37909452-84C13694-D231-402D-9EF9-72553030B8CCQ37995448-AC85477E-6CA5-4BD7-974D-EA0D293E0A42Q38068244-7E6E471B-C664-4510-A01C-E4E13E6F4898Q38116457-847E9E9F-4750-4CDB-B9EF-6AAB9126AAF1Q38261963-97E5311B-309B-444C-AE47-A463F8A06979Q38270318-0ACCF571-A72C-4811-9C25-D167B8297731Q38460704-A24BB3D3-43F5-46F1-86BD-4F9E6686614DQ38523725-1BBFD540-A413-4BD4-B3EC-8A269516BD7DQ38605185-BD478F20-1124-4640-980C-529D5D7C2B00Q38804615-E1C06A26-CF7A-4F29-8F31-2B5B54629971Q39125971-FEBC22D8-34BE-45FC-8FB0-28DF720CEC5DQ39289837-BF07BF90-FED2-401F-B401-AC483DE80DC1Q39375761-C89D9E60-7A6E-43A8-A32E-246E6563EAA1Q39403595-05D48160-CD1D-42E8-AB2C-A6C30BFB950AQ39832845-26E0C180-CD31-4101-A3A5-DBDA5BF57719
P2860
Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@ast
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@en
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@nl
type
label
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@ast
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@en
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@nl
prefLabel
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@ast
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@en
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@nl
P2093
P2860
P1433
P1476
Biodegradable gelatin micropar ...... f bone morphogenetic protein-2
@en
P2093
Antonios G Mikos
Hiroki Ueda
Yasuhiko Tabata
P2860
P304
P356
10.1016/J.ACTBIO.2008.04.002
P577
2008-04-22T00:00:00Z